Search
for
Sort by
Research 691–720 of 1000+
- Drug-induced hair colour changes
- Current advances in stem cell-based therapies for hair regeneration
- Adenoma of the Parathyroid Gland in Children
- Liposomes with an Ethanol Fraction as an Application for Drug Delivery
- Improvement in Androgenetic Alopecia (Stage V) Using Topical Minoxidil in a Retinoid Vehicle and Oral Finasteride
- Colchicine in Managing Skin Conditions: A Systematic Review
- The molecular pathogenesis of Trichilemmal carcinoma
- FUE Megasessions—Evolution of a Technique
- New-Generation Therapies for the Treatment of Hair Loss in Men
- Basic hair transplantation: 2007
- Facial Soft Tissue Augmentation in Males: An Anatomical and Practical Approach
- Development of phage-containing hydrogel for treating Enterococcus faecalis-infected wounds
- Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Classification of male-pattern hair loss
- Women’s Health Considerations for Lipid Management
- Fat Transfer for the Management of Soft Tissue Trauma: The Do's and the Don'ts
- Fabrication of Chimeric Hair Follicles for Skin Tissue Engineering
- Feline and Canine Cutaneous Lymphocytosis: Reactive Process or Indolent Neoplastic Disease?
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- Laser ablation of abnormal skin pigmentation post syndactyly release
- Controlled dissection for trichophytic closures with a Ledge Knife
- The Combined Use of Platelet-Rich Plasma and Adipose-Derived Mesenchymal Stem Cells Promotes Healing. A Review of Experimental Models and Future Perspectives
- Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Performance of an interferon-γ release assay-based test for cell-mediated immunity to SARS-CoV-2
- The First Syntheses of 16β-Chloro- and 16β-Bromo-cyproterone Acetate
- Hormonal and clinic evaluation of patients with moderate body hair growth
- Dual-Action Regenerative Therapies: Regeneration and Antimicrobial Effects of Platelet- and Marrow-Derived Biologics
- Partial regrowth of scalp hair in a patient treated with extracorporeal pholtochemotherapy and interferon ? 2a